Ebos profit falls but dividend holds steady as Chemist Warehouse era ends

Ebos profit falls but dividend holds steady as Chemist Warehouse era ends
Ebos has invested about $360m in new facilities including room to store the increasingly popular weight loss drugs such as Wegovy. (Image: Getty)
Rebecca Stevenson
Ebos’ profit has fallen, but it will pay investors the same dividend as it moves on without the Chemist Warehouse contract. For the year to June 30, the health and animal care group reported revenue of A$12.3 billion (NZ$13.6b) and underlying earnings of A$585 million. Its guidance was for underlying earnings before interest, taxation, depreciation and amortisation (ebitda) of between A$575m and A$600m. Revenue dropped 7.0% compared to the previous financial year.  It lost the $1.9b Chemist Warehouse contract in 2023....

More Markets

NZX lifts 0.2% as markets wait for US Fed decision
Markets Market Close

NZX lifts 0.2% as markets wait for US Fed decision

The S&P/NZX 50 gained 0.2% to 13,234.89 points on Tuesday.

Oceania forecasts sales lift as it targets debt
Property

Oceania forecasts sales lift as it targets debt

It said sales applications had lifted 23% between July and August.

New structure, powers for ComCom
Markets

New structure, powers for ComCom

Groceries, aviation, building supplies, digital services carparking all get a mention.

NZME shareholder Jim Grenon lifts investment in media firm
Markets

NZME shareholder Jim Grenon lifts investment in media firm

NZME shareholder and director Jim Grenon has lifted his investment in the media business for the second time in recent weeks, to just under 18%.A notice to the NZX on Monday stated Grenon had lifted his shareholding from 15.963% to 17.932%, after acquiring 3.7 million shares for...